Clinical trial to compare efficacy and safety of the Ivermectin 0.5% lotion and Permethrin 1% shampoo for treatment of pediculus humanus capitis infestation.

Gilaranco pharmaceutical and cosmecutical company0 个研究点目标入组 176 人开始时间: 待定最近更新: 2018年2月22日

适应症

试验速览

暂无简介。

•at least 6 months of age; presence of at least 3 live lice or 10 viable eggs (eggs found within 1.27 cm of the scalp); participants with good general health; signing the written informed consent by the capable participants or by their legal guardians for incapable ones; agree not to use any other forms of lice treatments except the test items; agrees not to cut their hair while participating in the study.

•history of irritation or sensitivity to Ivermectin or its components or other pediculicides products; presence of visible skin/scalp condition(s) that are not attributable to head lice infestation, such as an erythema score >2, blisters or vesicles at the treatment site ; presence of eczema or atopic dermatitis at the treatment site; history of treatment for head lice include OTC, home remedy or Rxin during the last 7 days; any condition or illness that, in investigator’s opinion, may compromise the objective of the protocol; pregnancy, lactation or planning to become pregnant during the study; participation in a previous investigational drug study within the past 30 days; prior participation in any Ivermectin trials

发起方

Gilaranco pharmaceutical and cosmecutical company